AI-based electrocardiogram (ECG) technology developer AliveCor announced today that it has closed a $65 million Series E financing round.
Mountain View, Calif.-based AliveCor plans to use proceeds from the financing round to accelerate the growth of its remote cardiology platform, both domestically and globally, according to a news release.
AliveCor is augmenting its artificial intelligence-powered ECG with telehealth services and detection and condition management services.
Omron, Khosla Ventures, WP Global Partners, Qualcomm Ventures and Bold Capital Partners, all existing investors, led the financing. AliveCor noted that its enhanced partnership with Omron in particular will position the company to include hypertension management within its service portfolio.
“We are grateful for the continued confidence of our investors,” AliveCor CEO Priya Abani said in the release. “This financing speaks to the transformative power our technology brings to the healthcare system. We remain positioned to fulfill our vision of delivering AI-based, remote cardiological services for the vast majority of cases when cardiac patients are not in front of their doctor.”